Smith & Nephew Dividends - SN.

Smith & Nephew Dividends - SN.

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Smith & Nephew Plc SN. London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
9.50 0.78% 1,227.00 10:16:18
Open Price Low Price High Price Close Price Previous Close
1,213.50 1,210.00 1,231.50 1,217.50
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Smith & Nephew SN. Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
29/07/2021InterimUSX14.431/12/202031/12/202130/09/202101/10/202127/10/20210
18/02/2021FinalUSX23.131/12/201931/12/202001/04/202106/04/202112/05/202137.5
29/07/2020InterimUSX14.431/12/201931/12/202001/10/202002/10/202028/10/20200
20/02/2020FinalUSX23.131/12/201831/12/201902/04/202003/04/202006/05/202037.5
31/07/2019InterimUSX14.431/12/201831/12/201903/10/201904/10/201930/10/20190
07/02/2019FinalUSX2231/12/201731/12/201804/04/201905/04/201908/05/201936
26/07/2018InterimUSX1431/12/201731/12/201804/10/201805/10/201831/10/20180
08/02/2018FinalUSX22.731/12/201631/12/201705/04/201806/04/201809/05/201835
27/07/2017InterimUSX12.331/12/201631/12/201705/10/201706/10/201701/11/20170
09/02/2017FinalUSX18.531/12/201531/12/201630/03/201731/03/201710/05/201730.8
28/07/2016InterimUSX12.331/12/201531/12/201606/10/201607/10/201625/10/20160
04/02/2016FinalUSX1931/12/201431/12/201521/04/201622/04/201611/05/201630.8
30/07/2015InterimUSX11.831/12/201431/12/201508/10/201509/10/201527/10/20150
05/02/2015FinalUSX18.631/12/201331/12/201416/04/201517/04/201506/05/201529.6
01/08/2014InterimUSX1131/12/201331/12/201422/10/201424/10/201411/11/20140
06/02/2014FinalUSX1731/12/201231/12/201320/04/201422/04/201407/05/201427.4
01/08/2013InterimUSX10.431/12/201231/12/201309/10/201311/10/201329/10/20130
07/02/2013FinalUSX16.231/12/201131/12/201217/04/201319/04/201308/05/201326.1
02/08/2012InterimUSX9.931/12/201131/12/201210/10/201212/10/201230/10/20120
02/02/2012FinalUSX10.831/12/201031/12/201118/04/201220/04/201209/05/201217.4
05/08/2011InterimUSX6.631/12/201031/12/201112/10/201114/10/201101/11/20110
10/02/2011FinalUSX9.8231/12/200931/12/201001/05/201103/05/201119/05/201115.82
05/08/2010InterimUSX631/12/200931/12/201013/10/201015/10/201002/11/20100
12/02/2010FinalUSX8.9331/12/200831/12/200921/04/201023/04/201012/05/201014.39
30/07/2009InterimUSX5.4630/12/200830/06/200914/10/200916/10/200903/11/20090
12/02/2009FinalUSX8.1231/12/200731/12/200815/04/200917/04/200908/05/200913.58
07/08/2008InterimUSX4.9628/12/200728/06/200815/10/200817/10/200807/11/20080
07/02/2008FinalUSX7.3831/12/200631/12/200716/04/200818/04/200809/05/200811.89
02/08/2007InterimUSX4.5130/12/200630/06/200717/10/200719/10/200709/11/20070
08/02/2007FinalUSX031/12/200531/12/200601/01/197001/01/197001/01/19705.62
08/02/2007InterimUSX3.4131/12/200531/12/200618/04/200720/04/200711/05/20070
27/07/2006InterimUSX2.2101/01/200601/07/200618/10/200620/10/200610/11/20060
09/02/2006FinalUSX3.531/12/200431/12/200519/04/200621/04/200612/05/20065.6
04/08/2005InterimUSX2.130/12/200430/06/200519/10/200521/10/200511/11/20050
03/02/2005FinalUSX3.231/12/200331/12/200420/04/200522/04/200513/05/20055.1
05/08/2004InterimUSX1.903/01/200403/07/200420/10/200422/10/200412/11/20040
05/02/2004FinalUSX3.131/12/200231/12/200321/04/200423/04/200414/05/20044.95
31/07/2003InterimUSX1.8528/12/200228/06/200313/08/200315/08/200312/09/20030
07/02/2003FinalUSX331/12/200131/12/200220/04/200322/04/200316/05/20034.8
01/08/2002InterimUSX1.830/12/200130/06/200216/10/200218/10/200215/11/20020
07/02/2002FinalUSX2.931/12/200031/12/200117/04/200219/04/200217/05/20024.65
02/08/2001InterimUSX1.7530/12/200030/06/200107/11/200109/11/200105/12/20010
15/02/2001FinalUSX2.831/12/199931/12/200018/04/200120/04/200118/05/20014.5
05/07/2000SpecialUSX37.1431/12/199931/12/200007/08/200004/08/200011/08/20000
08/08/2000InterimUSX1.701/01/200001/07/200006/11/200010/11/200006/12/20000
23/02/2000FinalUSX431/12/199831/12/199902/05/200008/05/200002/06/20006.5
09/08/1999InterimUSX2.503/01/199903/07/199901/11/199905/11/199908/12/19990
25/02/1999FinalUSX3.831/12/199731/12/199804/05/199910/05/199904/06/19996.2
26/02/1998FinalUSX3.831/12/199631/12/199701/06/199805/06/199801/07/19986.2

Top Dividend Posts

DateSubject
29/10/2021
12:07
value viper: SN. Updates next week
29/10/2021
12:07
value viper: Stryker (US) guides lower I understand- need to buy SN. !!
29/10/2021
11:10
essentialinvestor: Dividend reinvestment a. SN, is selling on 22.5 X FY 2022 and I'm guessing FY forecasts will be reduced. So yes it's a bargain, ain't it ;
14/9/2021
10:52
pugugly: OK Covid protective measures winding down but infections up though looking as though starting to go down but deaths starting to increase -However with restrictions coming off and winter coming very likley (imo)to be an acceration to the upside of both cases hospitalisations and deaths and therefore a decline in elective surgery BAD for SN. https://www.worldometers.info/coronavirus/country/uk/ Use above link if you wish to double check trends -
10/8/2021
16:10
ianood: EI, Interesting comment, I have 2 Stryker knees installed via their robotic arm system which guarantees precision of 1mm in limb length and <1 degree deviation in the rotation of the knee from the norm. I did think that SN would be a good base from which Stryker could scale up in UK/Europe but now having seen and felt the product results I am thinking why would they bother, it will gravitate to them by results alone! Also the Stryker system makes component parts comparatively easy to replace and therefore not a complete TKR in the extremely rare event of a failure!
10/8/2021
14:45
essentialinvestor: Look through the director dealing announcements over the last 6 months. A couple of senior employees in leadership roles appear to have sold and now don't seem to hold a single share in the Company?. That being said, now trading at a level I mentioned a few months back as a target price. There is no comparison with Stryker, it's risible to even mention the two in the same breath. Stryker's record is exceptional. Also worth considering some of the broker views, SN. lack a cementless knee product ATM and this is arguable proving costly. But ultimately the shares are no where near cheap even at current levels. Speculative buy at best Imv.
09/8/2021
08:46
suetballs: imo a good move ygor. Sold my holding in digs which is currently under offer and invested the proceeds here - more than doubled my holding. sn. looks good value and tbh I can't see much downside from here. Suet
08/6/2021
21:13
essentialinvestor: Terry holds Stryker, from memory. Not SN as far as I'm aware.
22/2/2021
10:32
suetballs: 4 brokers cut tp this am. Lowest £14.23 highest £19.85. Berenberg the highest still has sn. as a buy. Suet
22/2/2021
09:10
gclark: Well it is difficult to understand this continued drop as the prospects seem good in the near future - with us coming out of lockdown gradually and a much bigger emphasis on elective surgeries which have been delayed. All I can think now is that a large institution is selling, perhaps for other reasons than their view on SN.? Or may be, somebody in their company doesn't like the future prospects of SN. But I beg to differ with them - we shall see who is right!
ADVFN Advertorial
Your Recent History
LSE
SN.
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211201 10:31:55